How is the research output of Tufts Center for the Study of Drug Development?

Researchers at Tufts Center for the Study of Drug Development have published 241 articles, which have been cited by 11692. Of these publications, 8 articles have been published in exceptional journals such as Nature and Science.

Tufts Center for the Study of Drug Development Top...

241(top 24%)

articles

11.7K(top 15%)

citations

53(top 21%)

★★ articles

8(top 10%)

★★★ articles

2.7(top 17%)

Avg IF

40(top 18%)

H-Index

106(top 12%)

G-Index

journals

Most Cited Articles of Tufts Center for the Study of Drug Development in 2018

Title	Journal	Year	Citations
Assessing the Financial Value of Patient Engagement: A Quantitative Approach from CTTI's Patient Groups and Clinical Trials Project	Therapeutic Innovation and Regulatory Science	2018	62
Global Public Attitudes About Clinical Research and Patient Experiences With Clinical Trials	JAMA Network Open	2018	36
New Benchmarks Characterizing Growth in Protocol Design Complexity	Therapeutic Innovation and Regulatory Science	2018	16
The Use of Real-World Evidence and Data in Clinical Research and Postapproval Safety Studies	Therapeutic Innovation and Regulatory Science	2018	14
Estimated lifetime survival benefit of tumor treating fields and temozolomide for newly diagnosed glioblastoma patients	CNS Oncology	2018	14
Cost Drivers of a Hospital-Acquired Bacterial Pneumonia and Ventilator-Associated Bacterial Pneumonia Phase 3 Clinical Trial	Clinical Infectious Diseases	2018	11
Assessing Pharmaceutical Research and Development Costs	JAMA Internal Medicine	2018	11
Reforming China's drug regulatory system	Nature Reviews Drug Discovery	2018	10
Challenges Involved in the Development and Delivery of Abuse-deterrent Formulations of Opioid Analgesics	Clinical Therapeutics	2018	9
Assessing Study Start-up Practices, Performance, and Perceptions Among Sponsors and Contract Research Organizations	Therapeutic Innovation and Regulatory Science	2018	5
Assessing the Financial Benefits of Faster Development Times: The Case of Single-source Versus Multi-vendor Outsourced Biopharmaceutical Manufacturing	Clinical Therapeutics	2018	4
Rising Drug Costs Drives the Growth of Pharmacy Benefit Managers Exclusion Lists: Are Exclusion Decisions Value-Based?	Health Services Research	2018	2
Can Regenerative Medicine Help Close the Gap Between the Medicine Pipeline and Public Health Burden of Cardiovascular and Musculoskeletal Diseases?	Clinical Therapeutics	2018	1

Profile

Scientometrics

Tufts Center for the Study of Drug Development

United States of America (csdd.tufts.edu)

Most Cited Articles of Tufts Center for the Study of Drug Development in 2018